First private Moon landing attempt fails
ispace’s new spacecraft made it within touching distance of the lunar surface, but a last-minute malfunction dashed their hopes of a successful moon landing
Hormonal contraceptives and breast cancer: Weighing up the risks
A new study found that hormonal contraceptives are linked with a small increase in the risk of breast cancer, but should you stop taking the pill?
Mouldy Manny: How bad for you is a mouldy house?
We take a look at some of the myths surrounding household mould, and why you should probably text your landlord again about that damp patch…
Forever chemicals: New study begins to unravel exactly how PFAS affect our bodies
A new study has revealed the effect of PFAS, known as “forever chemicals”, on our natural biological processes for the first time.
UK lagging behind in the race against antibiotic resistance
Antibiotic resistance is on the rise – could bacteriophages be the solution?
In Conversation: Ex-NASA astronaut Bruce Melnick
We sat down with Bruce Melnick, former NASA astronaut, to discuss his time in space, his role at the Kennedy Space Center, and the ongoing Artemis Program.
To infinity and beyond: Looking at what’s next for science in 2023
The Mancunion bring you all the Science and Technology news you may have missed in 2022, and what to look forward to in 2023
12 days of Christmas: Five gold astronaut visors
On the 5th day of our 5 days of Christmas, find out about the scientific properties of gold!
Malaria vaccines: Where are we now?
Malaria kills 600 000 people per year, but an effective vaccine has remained difficult to find. Hope, however, may be on the horizon
New Alzheimer’s drug too good to be true?
Lecanemab is the first drug to change the course of Alzheimer’s disease, but two deaths during its clinical trial have raised questions about the drug’s safety.